. "M C Hornick" . . . . "article scientifique"@fr . . "articolo scientifico"@it . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@ast . . . . . . "wissenschaftlicher Artikel"@de . . "J F Blanco" . . . . . . "27" . "wetenschappelijk artikel"@nl . . . . . . . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects"@en . . . . . . . "3771507" . . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . . "article cient\u00EDfic"@ca . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@ast . . . . . . . . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@ast . "2" . . . . . . . . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A 05 \u064A\u0648\u0644\u064A\u0648 2012"@ar . . . "vedeck\u00FD \u010Dl\u00E1nok"@sk . . . . "vetenskaplig artikel"@sv . . . . "10.1038/LEU.2012.183" . . "A Li" . . "A Garcia-Gomez" . . "M H Tomasson" . . . . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . . . . . "D Piwnica-Worms" . "bilimsel makale"@tr . . . . . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@en . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2012"@ast . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@nl . . . . . . . . . . . . . . . . . . . . . . . . . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@en . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@en . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@nl . . "430-440" . . . "The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects."@nl . "R Vij" . . "22763387" . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u0438\u043F\u043D\u0456 2012"@uk . . . "artigo cient\u00EDfico"@pt . . . "K N Weilbaecher" . . . "videnskabelig artikel"@da . "C J Kirk" . . . . . . . . . . . . . . . . "scientific article published on 05 July 2012"@en . . . "M A Hurchla" . . "L Collins" . . . . . . "2012-07-05T00:00:00Z"^^ . . . . . . . .